1. Prognostic impact of RING box protein-1 (RBX1) expression in gastric cancer

   • Kazuhiro Migita
   • Tomoyoshi Takayama
   • Yoshiyuki Nakajima

   Original Article 29 November 2013 Pages: 601 - 609

   

2. Deregulation of the cell polarity protein Lethal giant larvae 2 (Lgl2) correlates with gastric cancer progression

   • Kyung Han Nam
   • Min A. Kim
   • Hye Seung Lee

   Original Article 13 December 2013 Pages: 610 - 620

   

3. Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit

   • Khurum Khan
   • Joo Ern Ang
   • Stan B. Kaye

   Original Article 21 January 2014 Pages: 621 - 629

   

4. Stratified phase II trial to establish the usefulness of the collagen gel droplet embedded culture-drug sensitivity test (CD-DST) for advanced gastric cancer

   • Hiroyuki Naitoh
   • Hiroshi Yamamoto
   • Tohru Tani

   Original Article Open access 08 December 2013 Pages: 630 - 637

   

5. Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization

   • Yoriko Yamashita-Kashima
   • Sei Shu
   • Naoki Harada

   Original Article Open access 12 January 2014 Pages: 638 - 647

   

6. Erratum to: Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization

   • Yoriko Yamashita-Kashima
   • Sei Shu
   • Naoki Harada

   Erratum Open access 20 March 2014 Pages: 648 - 648

7. Clinical characteristics and outcomes for gastric cancer patients aged 18–30 years

   • Hee Jung Park
   • Ji Yong Ahn
   • Jin-Ho Kim

   Original Article 11 January 2014 Pages: 649 - 660

   

8. A randomized trial to determine the diagnostic accuracy of conventional vs. jumbo forceps biopsy of gastric epithelial neoplasias before endoscopic submucosal dissection; open-label study

   • Hyo Keun Jeon
   • Ho Yoel Ryu
   • Sung Ho Won

   Original Article 13 December 2013 Pages: 661 - 668

   

9. Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: a prospective multicenter feasibility study

   • Kenshi Yao
   • Hisashi Doyama
   • Masahiko Tabuchi

   Original Article 10 January 2014 Pages: 669 - 679

   

10. Clinical management of esophagogastroduodenoscopy by clinicians under the former guidelines of the Japan Gastroenterological Endoscopy Society for patients taking anticoagulant and antiplatelet medications

    • Kunio Iwatsuka
    • Takuji Gotoda
    • Fuminori Moriyasu

    Original Article 08 January 2014 Pages: 680 - 685

    

11. Non-anesthesiologist administrated propofol (NAAP) during endoscopic submucosal dissection for elderly patients with early gastric cancer

    • Takuji Gotoda
    • Chika Kusano
    • Fuminori Moriyasu

    Original Article 08 January 2014 Pages: 686 - 691

12. Risk factors for submucosal and lymphovascular invasion in gastric cancer looking indicative for endoscopic submucosal dissection

    • Takeshi Yamada
    • Hiroaki Sugiyama
    • Ichinosuke Hyodo

    Original Article 10 December 2013 Pages: 692 - 696

    

13. Secondary endoscopic submucosal dissection for residual or recurrent tumors after gastric endoscopic submucosal dissection

    • Shu Hoteya
    • Toshiro Iizuka
    • Naohisa Yahagi

    Original Article 06 December 2013 Pages: 697 - 702

    

14. Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer

    • In Rae Cho
    • Jun Chul Park
    • Yong Chan Lee

    Original Article 19 January 2014 Pages: 703 - 710

    

15. Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial

    • Gianluca Tomasello
    • Wanda Liguigli
    • Rodolfo Passalacqua

    Original Article 27 November 2013 Pages: 711 - 717

    

16. Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer

    • Luigi Di Lauro
    • Patrizia Vici
    • Marcello Maugeri-Saccà

    Original Article 08 December 2013 Pages: 718 - 724

    

17. Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial

    • Fabio Pacelli
    • Fausto Rosa
    • Giovanni Battista Doglietto

    Original Article 30 November 2013 Pages: 725 - 732

    

18. Duodenal stump fistula after gastric surgery for malignancies: a retrospective analysis of risk factors in a single centre experience

    • Elena Orsenigo
    • Massimiliano Bissolati
    • Carlo Staudacher

    Original Article 08 January 2014 Pages: 733 - 744

    

19. Early-onset diffuse gastric cancer associated with a de novo large genomic deletion of CDH1 gene

    • Shinya Sugimoto
    • Hidetaka Yamada
    • Hirokazu Komatsu

    Case Report Open access 29 June 2013 Pages: 745 - 749

    

20. Hereditary diffuse gastric cancer in a Japanese family with a large deletion involving CDH1

    • Masayoshi Yamada
    • Takeo Fukagawa
    • Hitoshi Katai

    Case Report 15 September 2013 Pages: 750 - 756

    

21. Comments on “Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study”

    • Michitaka Honda
    • Akira Kuriyama
    • Toshiaki A. Furukawa

    Letter to the Editor 28 January 2014 Pages: 757 - 758

22. A new way to experience the International Gastric Cancer Association Congress: the Web Round Tables

    • Paolo Morgagni
    • Giuseppe Verlato
    • Giovanni de Manzoni

    Meeting Report 25 December 2013 Pages: 759 - 764